Eytan Ruppin: Next Generation Transcriptomics-based Precision Oncology

About this Class

We invite you to join us for the Neuro-Oncology Visiting Scholar Lecture scheduled for next week by Eytan Ruppin, M.D. Ph.D: Next Generation Transcriptomics-based Precision Oncology Eytan Ruppin received his M.D. and Ph.D. (Computer Science) from Tel-Aviv University where he has served as a professor of Computer Science & Medicine since 1995, conducting computational multi-disciplinary research spanning a wide variety of topics, including neuroscience, evolutionary computation, natural language processing, machine learning and systems biology. He joined the University of Maryland in July 2014 as a Computer Science professor and director of its center for bioinformatics and computational biology (CBCB), before joining the NCI in January 2018, where he co-founded and is Chief of its Cancer Data Science Lab. Studying cancer metabolism, his lab has been involved in identifying the first metabolic synthetic lethal cancer drug target and in the discovery of the link between urea cycle dysregulation and response to immunotherapy, among others. His recent research focus is on developing new approaches for transcriptomics-based precision oncology, which are now moving into clinical prospective testing. Dr. Ruppin is a member of the editorial board of Molecular Systems Biology and a fellow of the International Society for Computational Biology (ISCB). He has recently received the NCI Director award (2022) and the Delano Award for Computational Biosciences (2023) for his contributions for advancing transcriptomics-based precision oncology. Dr. Ruppin is also a co-founder of a few startup companies involved in precision medicine and cancer drug discovery. Meeting number:2319 071 3551